Tumor mutational burden (TMB): Assessment of inter- and intra-tumor heterogeneity.
2019
27Background: As an emerging biomarker, a high TMB is associated with response to immune checkpoint inhibitors. The tissue selected for molecular analysis could be critical for accurate TMB assessm...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
5
Citations
NaN
KQI